Unbound MEDLINE

Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations.

Abstract

Bohring-Opitz syndrome (BOS) is a rare condition characterized by facial anomalies, multiple malformations, failure to thrive and severe intellectual disabilities. Recently, the cause was identified on the basis of de novo heterozygous mutations in the ASXL1 gene. We report on two novel cases carrying two previously undescribed mutations (c.2407_2411del5 [p.Q803TfsX17] and c.2893C>T [p.R965X]). These new data further support ASXL1 as cause of BOS and may contribute to a more precise definition of the phenotype caused by the disruption of this gene.

Links

  • Publisher Full Text
  • Authors

    Magini P, Della Monica M, Uzielli ML, Mongelli P, Scarselli G, Gambineri E, Scarano G, Seri M

    Institution

    Dipartimento di Scienze Ginecologiche, Ostetriche e Pediatriche, Università di Bologna, Policlinico Sant'Orsola Malpighi, U.O. Genetica Medica, Bologna, Italy. pamela.magini@unibo.it

    Source

    American journal of medical genetics. Part A 158A:4 2012 Apr pg 917-21

    MeSH

    Abnormalities, Multiple
    Child
    Codon, Nonsense
    Craniosynostoses
    Female
    Frameshift Mutation
    Humans
    Infant
    Intellectual Disability
    Male
    Phenotype
    Repressor Proteins

    Pub Type(s)

    Case Reports
    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22419483